公司概覽
業務類別 --
業務概覽 Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2024, approximately one quarter of revenue comes from its Japan businesses, which will shrink in the future as the company expands its globalfootprint. Its primary growth driver is its leading platform of antibody drug conjugates, or ADCs. Its lead ADCs are Enhertu (HER2), Datroway (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu was first approved in the US in December 2019, and Datroway was first approved in January 2025.
公司地址 3-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, JPN, 103-8426
電話號碼 +81 362251111
傳真號碼 --
公司網頁 https://www.daiichisankyo.co.jp
員工數量 19765
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Hiroyuki Okuzawa Director, President and Chief Executive Officer -- 19/06/2026
Mr. Takashi Matsumoto Director and Senior Executive Officer -- 19/06/2026
 
董事會成員
董事會 職務 更新日期
Mr. Joseph Kenneth Keller Director 19/06/2026
Mr. Takaaki Nishii Independent Director 19/06/2026
Mr. Hiroyuki Okuzawa Director, President and Chief Executive Officer 19/06/2026
Mr. Yo Honma Independent Director 19/06/2026
Mr. Yasuhiro Komatsu Independent Director 19/06/2026
Mr. Takashi Matsumoto Director and Senior Executive Officer 19/06/2026
Ms. Reiko Kinoshita Independent Director 19/06/2026
Ms. Shizuko Ueno Director 19/06/2026
Mr. Akihiro Watanabe Independent Director 19/06/2026
Mr. Stuart Mackey Director 19/06/2026
 
所屬ETF (更新日期: 14/11/2026 03:13)
代號 名稱 佔比% ▼ 持有日期
DTANSparkline International IntangibleValETF0.001%30/10/2026
ACIVHartford Alpha Capture Intl Val ETF0.001%31/10/2026
IGAVoya Global Advantage and Premium Opp0.001%30/09/2026
FEDMNorthern Trust ESG&ClmtDevMktsexUSCorETF0.001%30/10/2026
IMFLInvesco Intl Dev Dynmc Mltfctr ETF0.001%30/10/2026
IFLRInnovator International Dev Mgd Flr ETF0.0005%30/10/2026
TIERT. Rowe Price Intl Equity Research ETF0.0005%31/10/2026
AVSDAvantis Responsible International Eq ETF0.0005%30/10/2026
WIMAWisdomTree International Adaptive MovAvr0.0004%30/10/2026
VDGVanguard Developed Mkts ex US Gr Idx ETF0.0003%30/09/2026
SROICalamos Antetokounmpo Global Sus Eqs ETF0.0003%30/09/2026
NZACState Street®SPDR®MSCIACWIClmPrsAlgndETF0.0003%30/10/2026
GLOFiShares Global Equity Factor ETF0.0002%30/10/2026
DMXUXtrackers Blmbrg Dev Mkts ex US Eq ETF0.0002%29/10/2026
QWLDState Street® SPDR® MSCI Wld StrtFcs ETF0.0002%30/10/2026
JSTCAdasina Social Justice All Cp Glbl ETF0.0002%30/10/2026
ENHIiShares Enhanced International Actv ETF0.0001%30/10/2026
DXIVDimensional International Vector Eq ETF0.0001%30/10/2026
IBFRInnovator International Dev Mgd 10BfrETF0.0001%30/10/2026
ESIMEventide International ETF0.0001%30/10/2026
  1    2    3    4   5    6  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.